SCHEDULE 13G
Statement of Beneficial Ownership
Allogene Therapeutics, Inc. Filed Acc 0000902664-25-000983
Loading xslSCHEDULE_13G_X01/primary_doc.xml…
Allogene Therapeutics, Inc. Filed Acc 0000902664-25-000983
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…